clinical trial · NCT06128369
Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery
Oculis·phase3·terminated·n = 117
Inflammation EyePain, PostoperativeCataractDexamethasone Ophthalmic SuspensionVehicle of OCS-01
brief summary
The goal of this clinical trial is to evaluate the efficacy and safety of OCS-01 in treating inflammation and pain in subjects following cataract surgery.
started
Dec 18, 2023
primary completion
May 2, 2024
completion
May 9, 2024
last updated
Dec 10, 2024
detailed description
This is a multi-center, randomized, double-masked, vehicle-controlled study, designed to evaluate the efficacy and safety of OCS-01 compared to vehicle in treating inflammation and pain following cataract surgery. Subjects will be randomized 1:1 to receive OCS-01 or vehicle once daily.
official title
A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Ophthalmic Suspension in the Treatment of Inflammation and Pain Following Cataract Surgery
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol